Kuo S.-C.Shih S.-M.Hsieh L.-Y.Lauderdale T.-L.Y.YEE-CHUN CHENHsiung C.A.SHAN-CHWEN CHANG2020-12-302020-12-3020170305-7453https://www.scopus.com/inward/record.uri?eid=2-s2.0-85020113043&doi=10.1093%2fjac%2fdkw595&partnerID=40&md5=3501ac6e7fd4ccade484c815b37a4177https://scholars.lib.ntu.edu.tw/handle/123456789/535969[SDGs]SDG1[SDGs]SDG3antibiotic agent; cephalosporin derivative; macrolide; penicillin derivative; quinolone derivative; sulfonamide; tetracycline derivative; trimethoprim; antiinfective agent; antibiotic resistance; drug monitoring; drug use; health care personnel; human; Letter; medical record; medical service; national health insurance; outpatient; peer review; policy; practice guideline; prescription; reinforcement; Taiwan; world health organization; antibiotic resistance; drug database; drug utilization review; health insurance; statistics and numerical data; Anti-Bacterial Agents; Databases, Pharmaceutical; Drug Resistance, Microbial; Drug Utilization Review; Humans; Insurance, Health; TaiwanAntibiotic restriction policy paradoxically increased private drug consumptions outside Taiwan's National Health Insuranceletter10.1093/jac/dkw59528175312